Risk adjusted benchmarking of clinical anastomotic leakage rate after total mesorectal excision in the context of an improvement project
F. Penninckx
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorS. Fieuws
I-Biostat, KU Leuven, and Universiteit Hasselt, Belgium
Search for more papers by this authorW. Ceelen
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorP. Demetter
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorK. Haustermans
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorJ. Van de Stadt
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorK. Vindevoghel
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authoron behalf of PROCARE
Search for more papers by this authorF. Penninckx
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorS. Fieuws
I-Biostat, KU Leuven, and Universiteit Hasselt, Belgium
Search for more papers by this authorW. Ceelen
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorP. Demetter
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorK. Haustermans
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorJ. Van de Stadt
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authorK. Vindevoghel
PROCARE p/a Foundation Belgian Cancer Registry, Brussels, Belgium
Search for more papers by this authoron behalf of PROCARE
Search for more papers by this authorAbstract
Aim Anastomotic leakage (AL) after total mesorectal excision (TME) is a major adverse event. This study evaluates variability in AL between centres participating on a voluntary basis in PROCARE, a Belgian improvement project, and how further improvement of the AL rate might be achieved.
Method Between January 2006 and March 2011, detailed data on 1815 patients (mean age 65.5 years, 63% male) who underwent elective TME with colo-anal reconstruction for rectal cancer were registered by 48 centres. Variability in early clinical AL rate was analysed before and after adjustment for gender, age > 60 years, American Society of Anesthesiologists score of 3 or more and body mass index > 25 kg/m2.
Results The overall AL rate was 6.7% (95% CI 5.6%–7.9%). Early AL required reoperation in 86.8% of patients. It increased length of hospital stay from 14.7 days to 32.4 days and in-hospital mortality from 1.1% to 4.8%. Statistically significant variability in AL rate between centres was not observed, either before or after risk adjustment. Nonetheless, further improvement may be achievable in some centres by targeting the adjusted performance of better performing centres. These centres used neoadjuvant treatment, rectal irrigation, mobilization of the splenic flexure, resection of the sigmoid colon, side-to-end colo-anastomosis with or without pouch and defunctioning stoma at primary surgery in a significantly higher proportion of patients than less well performing centres.
Conclusion The overall AL rate was low but needs to be interpreted with caution because of incomplete registration. Further improvement might be achieved by adopting the approach of better performing centres.
References
- 1 Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm colorectal cancer study group, Basingstoke bowel cancer research project. Lancet 2000; 356: 93–6.
- 2 Engel AF, Oomen JL, Eijsbouts QA, Cuesta MA, van de Velde CJ. Nationwide decline in annual numbers of abdomino-perineal resections: effect of a successful national trial? Colorectal Dis 2003; 5: 180–4.
- 3 Matthiessen P, Hallböök O, Rutegård J, Sjödahl R. Population-based study of risk factors for postoperative death after anterior resection of the rectum. Br J Surg 2006; 93: 498–503.
- 4 Khan AA, Wheeler JM, Cunningham C, George B, Kettlewell M, Mortensen NJ. The management and outcome of anastomotic leaks in colorectal surgery. Colorectal Dis 2008; 10: 587–92.
- 5 Bertelsen CA, Andreasen AH, Jørgensen T, Harling H; Danish Colorectal Cancer Group. Anastomotic leakage after curative anterior resection for rectal cancer: short and long-term outcome. Colorectal Dis 2010; 12: e76–81.
- 6 Boccola MA, Buettner PG, Rozen WM et al. Risk factors and outcomes for anastomotic leakage in colorectal surgery: a single-institution analysis of 1576 patients. World J Surg 2011; 35: 186–95.
- 7 Gagliardi AR, Simunovic M, Langer B et al. Development of quality indicators for colorectal cancer surgery, using a 3-step modified Delphi approach. Can J Surg 2005; 48: 441–52.
- 8 Malin JL, Schneider EC, Epstein AM, Adams J, Emanuel EJ, Kahn KL. Results of the National Initiative for cancer care quality: how can we improve the quality of cancer care in the United States? J Clin Oncol 2006; 24: 626–34. Erratum in: J Clin Oncol 2006; 24: 1966.
- 9 Patwardhan MB, Samsa GP, McCrory DC et al. Cancer care quality measures: diagnosis and treatment of colorectal cancer. Evid Rep Technol Assess 2006; 138: 1–116.
- 10 Bittner R, Burghardt J, Gross E et al. Qualitätsindikatoren bei Diagnostik und Therapie des Rektumkarzinoms. Zentralbl Chir 2007; 132: 85–94.
- 11 Vlayen J, Verstreken M, Mertens C, Van Eycken E, Penninckx F (2008) Quality of rectal cancer care. Phase 2: development and testing of a set of quality indicators. Good Clinical Practice (GCP). KCE reports 81A (D/2008/10.273/38), Federaal Kenniscentrum voor de Gezondheidszorg (KCE), Brussel.
- 12 Matthiessen P, Hallböök O, Andersson M, Rutegård J, Sjödahl R. Risk factors for anastomotic leakage after anterior resection of the rectum. Colorectal Dis 2004; 6: 462–9.
- 13 Eriksen MT, Wibe A, Norstein J, Haffner J, Wiig JN; Norwegian Rectal Cancer Group. Anastomotic leakage following routine mesorectal excision for rectal cancer in a national cohort of patients. Colorectal Dis 2005; 7: 51–7.
- 14 Jestin P, Påhlman L, Gunnarsson U. Risk factors for anastomotic leakage after rectal cancer surgery: a case–control study. Colorectal Dis 2008; 10: 715–21.
- 15 Jung SH, Yu CS, Choi PW et al. Risk factors and oncologic impact of anastomotic leakage after rectal cancer surgery. Dis Colon Rectum 2008; 51: 902–8.
- 16 Lee WS, Yun SH, Roh YN et al. Risk factors and clinical outcome for anastomotic leakage after total mesorectal excision for rectal cancer. World J Surg 2008; 32: 1124–9.
- 17 Bertelsen CA, Andreasen AH, Jørgensen T, Harling H; Danish Colorectal Cancer Group. Anastomotic leakage after anterior resection for rectal cancer: risk factors. Colorectal Dis 2010; 12: 37–43.
- 18 Swedish Rectal Cancer Trial. Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Br J Surg 1993; 80: 1333–6.
- 19 Kapiteijn E, Kranenbarg EK, Steup WH et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur J Surg 1999; 165: 410–20.
- 20 Sauer R, Fietkau R, Wittekind C et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 2001; 177: 173–81.
- 21 Sebag-Montefiore D, Stephens RJ, Steele R et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811–20.
- 22 Garlipp B, Ptok H, Schmidt U, Meyer F, Gastinger I, Lippert H. Neoadjuvant chemoradiotherapy for rectal carcinoma: effects on anastomotic leak rate and postoperative bladder dysfunction after non-emergency sphincter-preserving anterior rectal resection. Results of the Quality Assurance in Rectal Cancer Surgery multicenter observational trial. Langenbecks Arch Surg 2010; 395: 1031–8.
- 23 Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, Parneix M. Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg 1998; 85: 355–8.
- 24 Xiao L, Zhang WB, Jiang PC et al. Can transanal tube placement after anterior resection for rectal carcinoma reduce anastomotic leakage rate? A single-institution prospective randomized study World J Surg 2011; 35: 1367–77.
- 25 Akasu T, Takawa M, Yamamoto S, Yamaguchi T, Fujita S, Moriya Y. Risk factors for anastomotic leakage following intersphincteric resection for very low rectal adenocarcinoma. J Gastrointest Surg 2010; 14: 104–11.
- 26 Cong ZJ, Fu CG, Wang HT, Liu LJ, Zhang W, Wang H. Influencing factors of symptomatic anastomotic leakage after anterior resection of the rectum for cancer. World J Surg 2009; 33: 1292–7.
- 27 Kruschewski M, Rieger H, Pohlen U, Hotz HG, Buhr HJ. Risk factors for clinical anastomotic leakage and postoperative mortality in elective surgery for rectal cancer. Int J Colorectal Dis 2007; 22: 919–27.
- 28 Eberl T, Jagoditsch M, Klingler A, Tschmelitsch J. Risk factors for anastomotic leakage after resection for rectal cancer. Am J Surg 2008; 196: 592–8.
- 29 Huh JW, Kim HR, Kim YJ. Anastomotic leakage after laparoscopic resection of rectal cancer: the impact of fibrin glue. Am J Surg 2010; 199: 435–41.
- 30 Ito M, Sugito M, Kobayashi A, Nishizawa Y, Tsunoda Y, Saito N. Relationship between multiple numbers of stapler firings during rectal division and anastomotic leakage after laparoscopic rectal resection. Int J Colorectal Dis 2008; 23: 703–7.
- 31 Rahbari NN, Weitz J, Hohenberger W et al. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery 2010; 147: 339–51.
- 32 Spiegelhalter D. Funnel plots for comparing institutional performance. Stat Med 2005; 24: 1185–202.
- 33 Wong G, Mason W. The hierarchical logistic regression model for multilevel analysis. JASA 1985; 80: 513–24.
- 34 Thomas N, Longford NT, Rolph JE. Empirical Bayes methods for estimating hospital-specific mortality rates. Stat Med 1994; 13: 889–903.
- 35 Böhning D (1999) Computer-assisted analysis of mixtures and applications: meta-analysis, disease mapping and others. Monographs on Statistics and Applied Probability, p. 81. Chapman & Hall/CRC, Boca Raton, FL.
- 36 den Dulk M, Smit M, Peeters KC et al. ; Dutch Colorectal Cancer Group. A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospective study. Lancet Oncol 2007; 8: 297–303.
- 37 Pata G, D’Hoore A, Fieuws S, Penninckx F. Mortality risk analysis following routine vs selective defunctioning stoma formation after total mesorectal excision for rectal cancer. Colorectal Dis 2009; 11: 797–805.
- 38 Matthiessen P, Hallböök O, Rutegård J, Simert G, Sjödahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg 2007; 246: 207–14.
- 39 Matthiessen P, Lindgren R, Hallböök O, Rutegård J, Sjödahl R; Rectal Cancer Trial on Defunctioning Stoma Study Group. Symptomatic anastomotic leakage diagnosed after hospital discharge following low anterior resection for rectal cancer. Colorectal Dis 2010; 12: e82–7.